...
首页> 外文期刊>European review for medical and pharmacological sciences. >Analysis of the relationship between microRNA-31 and interferon regulatory factor-1 in hepatocellular carcinoma cells
【24h】

Analysis of the relationship between microRNA-31 and interferon regulatory factor-1 in hepatocellular carcinoma cells

机译:肝细胞癌细胞中微荷-31和干扰素调控因子1的关系分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: MicroRNAs (miRNAs) play a role in the pathogenesis of hepatocellular carcinoma (HCC). This study was designed to elucidate the role of microRNA-31 (miR-31) in HCC. MATERIALS AND METHODS: HuH7 cell lines were transfected with miR-31 mimic or miR-31 inhibitor to investigate the role of miR-31 in regulating interferon regulatory factor-1 (IRF-1). The mRNA and protein expression levels of IRF-1 were quantitatively detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and Western blot, respectively. Subsequently, Dual-Luciferase reporter assay was also performed. RESULTS: The expression level of miR-31 was significantly up-regulated in HuH7 cells when compared with that in primary human hepatocytes (hHC). Dual-Luciferase reporter assay indicated that IRF-1 was the direct target of miR-31. The expression levels of IRF-1 were decreased in HuH7 and HepG2 cell lines. IRF-1 was negatively correlated with miR-31 in HCC tissues and paired adjacent tissues. The expression level of miR-31 was inversely correlated with IRF-1. MiR-31 inhibitor up-regulated the expression levels of IRF-1 in HuH7 cells, whereas miR-31 mimic down-regulated the expression levels of IRF-1. Furthermore, the miR-31 mimic repressed IRF-1-3’UTR reporter activity, whereas the miR-31 inhibitor enhanced IRF-1-3’UTR reporter activity depending on the concentration of miR-31 mimic and miR-31 inhibitor. CONCLUSIONS: These results indicated that miR-31 can regulate the expression level of IRF-1 in HCC, which probably provided novel theoretical evidence for the application of target miR-31 treatment of HCC.
机译:目的:Micrornas(miRNA)在肝细胞癌(HCC)的发病机制中发挥作用。本研究旨在阐明MicroRNA-31(miR-31)在HCC中的作用。材料和方法:用miR-31模拟或miR-31抑制剂转染Huh7细胞系,研究miR-31在调节干扰素调节因子-1(IRF-1)中的作用。通过定量实时 - 聚合酶链反应(QRT-PCR)和Western印迹定量检测IRF-1的mRNA和蛋白表达水平。随后,还进行了双荧光素酶报告结果。结果:与原发性人肝细胞(HHC)相比,Huh7细胞中MiR-31的表达水平显着上调。双荧光素酶报告器测定表明,IRF-1是MIR-31的直接靶标。 IRF-1的表达水平在HUH7和HepG2细胞系中降低。 IRF-1与HCC组织中的miR-31呈负相关,并配对相邻组织。 miR-31的表达水平与IRF-1相反。 miR-31抑制剂上调了Huh7细胞中IRF-1的表达水平,而MiR-31模拟了下调IRF-1的表达水平。此外,miR-31模拟压抑的IRF-1-3'UTR报告活动,而MiR-31抑制剂提高了IRF-1-3'UTR报告活性,这取决于miR-31模拟和miR-31抑制剂的浓度。结论:这些结果表明MIR-31可以调节HCC中IRF-1的表达水平,这可能为靶MIR-31治疗HCC的应用提供了新的理论证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号